Empyrean Capital Partners’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,197,300
| Closed | -$212M | – | 77 |
|
|
2020
Q1 | $212M | Sell |
1,197,300
-76,200
| -6% | -$13.5M | 14.58% | 2 |
|
|
2019
Q4 | $243M | Hold |
1,273,500
| – | – | 16.01% | 1 |
|
|
2019
Q3 | $214M | Buy |
1,273,500
+246,300
| +24% | +$41.4M | 11.15% | 1 |
|
|
2019
Q2 | $172M | Buy |
+1,027,200
| New | +$172M | 7.65% | 1 |
|
|
2016
Q1 | – | Sell |
-179,210
| Closed | -$56M | – | 99 |
|
|
2015
Q4 | $56M | Buy |
179,210
+70,210
| +64% | +$21.9M | 2.07% | 10 |
|
|
2015
Q3 | $29.6M | Sell |
109,000
-336,753
| -76% | -$91.5M | 1.46% | 16 |
|
|
2015
Q2 | $135M | Buy |
445,753
+100,000
| +29% | +$30.3M | 6.32% | 2 |
|
|
2015
Q1 | $103M | Sell |
345,753
-198,247
| -36% | -$59M | 5.12% | 5 |
|
|
2014
Q4 | $140M | Buy |
+544,000
| New | +$140M | 7.98% | 1 |
|
|
2014
Q3 | – | Sell |
-318,000
| Closed | -$70.9M | – | 60 |
|
|
2014
Q2 | $70.9M | Buy |
+318,000
| New | +$70.9M | 2.5% | 7 |
|